NCT01613365View on ClinicalTrials.gov

Oropharyngeal and Nasopharyngeal Decontamination With Chlorhexidine Gluconate in the Reduction of the Postoperative Morbidity and Mortality After Major Pulmonary Resections

PHASE3CompletedINTERVENTIONAL

Enrollment

474

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Infections and Respiratory Infectious

Interventions

DRUG

Chlorhexidine Gluconate

Oropharyngeal and nasopharyngeal decontamination with Chlorhexidine Gluconate

DRUG

Placebo

Oropharyngeal and nasopharyngeal decontamination with placebo

Trial Locations (1)

13354

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT01613365 - Oropharyngeal and Nasopharyngeal Decontamination With Chlorhexidine Gluconate in the Reduction of the Postoperative Morbidity and Mortality After Major Pulmonary Resections | Biotech Hunter | Biotech Hunter